55 / 100

Assoc Prof Dr. Federica Rinaldi, Nanomedicine Award, Best Researcher Award

Associate Professor at Sapienxa University of Rome, Italy

Summary:

Dr. Federica Rinaldi is an Associate Professor in the Department of Chemistry and Technologies of Drugs at Sapienza University of Rome. She obtained her Ph.D. in Pharmaceutical Sciences from the University of Rome “La Sapienza” in 2012, with a focus on novel targeting strategies using vesicles and synthetic surfactants. Dr. Rinaldi’s research interests span various aspects of pharmaceutical sciences, including nanotechnology for drug delivery, formulation development, targeted drug delivery systems, pharmacokinetics, pharmacodynamics, and pharmaceutical technology legislation. She is actively involved in teaching and mentoring students at both undergraduate and graduate levels. Dr. Rinaldi is a member of several professional societies and has received recognition for her contributions to nanotechnology and drug delivery research. Her work aims to advance pharmaceutical sciences and improve therapeutic outcomes through innovative drug delivery approaches.

Professional Profile:

Scopus Profile

Orcid Profile

👩‍🎓Education & Qualification:

University Graduation (2008):

  • Institution: University of Rome “La Sapienza”
  • Degree: Chemistry and Pharmaceutical Technologies
  • Faculty: Faculty of Pharmacy

License (2009):

  • Institution: University of Rome “La Sapienza”
  • License: License to practice the profession of Pharmacist

PhD (2012):

  • Institution: University of Rome “La Sapienza”
  • Degree: Pharmaceutical Sciences
  • Department: Department of Drug Chemistry and Technologies, Faculty of Pharmacy

Professional Experience:  

Dr. Federica Rinaldi has extensive professional experience in academia and research. She currently serves as an Associate Professor in Pharmaceutical Technologies at the Department of Chemistry and Technologies of Drug at Sapienza University of Rome. Prior to this, she held the position of National Scientific Qualification (ASN) as an associate professor at the Ministero dell’Istruzione dell’UniversitĂ  e della Ricerca (MIUR). Dr. Rinaldi has been actively involved in teaching and research, contributing significantly to the field of pharmaceutical sciences. She has supervised laboratory experiences, courses, and seminars at various institutions, including the University of Rome “La Sapienza” and Tor Vergata University of Rome. Additionally, she has served as a member of examination commissions and has been recognized for her contributions to nanotechnology and drug delivery by the European Commission. Dr. Rinaldi’s dedication to academia and research is evident through her numerous memberships in professional societies and her continuous commitment to innovative teaching methodologies.

Research Interest:

Nanotechnology for Drug Delivery: Dr. Rinaldi is interested in exploring innovative nanocarriers and vesicles for drug delivery applications, with a particular emphasis on improving drug targeting and bioavailability.

Formulation Development: She investigates novel formulation strategies to enhance the stability, efficacy, and safety of pharmaceutical products, including nanoemulsions, niosomes, and other nanocarrier systems.

Targeted Drug Delivery Systems: Dr. Rinaldi explores advanced targeting strategies to achieve site-specific drug delivery, including pH-sensitive vesicles and ligand-mediated drug targeting approaches.

Pharmacokinetics and Pharmacodynamics: She studies the pharmacokinetic and pharmacodynamic properties of drug formulations, aiming to optimize drug release kinetics and therapeutic outcomes.

Pharmaceutical Technology and Legislation: Dr. Rinaldi is involved in research related to pharmaceutical technology advancements, as well as the regulatory aspects governing pharmaceutical products, including legislation and quality control.

Publication Top Noted:

Effect of Ciprofloxacin-Loaded Niosomes on Escherichia coli and Staphylococcus aureus Biofilm Formation

  • Authors: Maurizi, L., Forte, J., Ammendolia, M.G., Carafa, M., Longhi, C.
  • Journal: Pharmaceutics
  • Year: 2022
  • Volume: 14
  • Issue: 12
  • Pages: 2662

Ultrastable shelled PFC nanobubbles: A platform for ultrasound-assisted diagnostics, and therapy

  • Authors: Hanieh, P.N., Ricci, C., Bettucci, A., Del Favero, E., Marianecci, C.
  • Journal: Nanomedicine: Nanotechnology, Biology, and Medicine
  • Year: 2022
  • Volume: 46
  • Pages: 102611

Almond oil O/W nanoemulsions: Potential application for ocular delivery

  • Authors: Hanieh, P.N., Bonaccorso, A., Zingale, E., Pignatello, R., Carafa, M.
  • Journal: Journal of Drug Delivery Science and Technology
  • Year: 2022
  • Volume: 72
  • Pages: 103424

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment

  • Authors: Hanieh, P.N., Consalvi, S., Forte, J., Carafa, M., Marianecci, C.
  • Journal: Pharmaceutics
  • Year: 2022
  • Volume: 14
  • Issue: 3
  • Pages: 610

pH-responsive oleic acid based nanocarriers: Melanoma treatment strategies

  • Authors: Rinaldi, F., Forte, J., Pontecorvi, G., Puglisi, R., Carafa, M.
  • Journal: International Journal of Pharmaceutics
  • Year: 2022
  • Volume: 613
  • Pages: 121391

 

 

 

 

Federica Rinaldi | Nanomedicine Award | Best Researcher Award

You May Also Like